Literature DB >> 24325958

Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.

Jonathan Forsey1, Lee Benson1, Evelyn Rozenblyum1, Mark K Friedberg1, Luc Mertens2.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common form of inherited cardiomyopathy. Echocardiography is the mainstay of screening and disease surveillance, and genetic testing has identified a carrier population without hypertrophy. The aim of this study was to investigate whether changes in left ventricular (LV) function are detectable before the advent of hypertrophy.
METHODS: Fourteen children with genotype-positive, phenotype-negative HCM were identified (12 male; median age, 9.14 years; range, 1.91-15.9 years; median weight, 34.6 kg; range, 15-92.1 kg) and compared with age-matched and sex-matched healthy controls. All children underwent full echocardiographic studies using an extensive functional protocol, including two-dimensional dimensions, Doppler tissue imaging, and two-dimensional speckle-tracking echocardiography.
RESULTS: There were no differences in LV wall thickness, chamber dimensions, length, and shortening fraction between the groups. Doppler tissue imaging in children with HCM demonstrated mildly reduced septal velocities, notably A' (5.9 cm/sec [range, 4-8.9 cm/sec] vs 6.7 cm/sec [range, 5.2-9.5 cm/sec]; P = .009). Circumferential and longitudinal strain was similar between groups. Mean apical circumferential deformation was increased in the HCM group (-24.6 ± 3.8% vs -22.2 ± 2.5%, P = .04). There were significant increases in basal and apical rotation and LV twist in children with HCM, most marked at the apex (11.7 ± 4.4° vs 5.3 ± 2.5°, P = .0001). On receiver operating characteristic curve analysis, apical rotation > 7° conferred 83% sensitivity and 82% specificity for predicting HCM (area under the curve, 0.919; P = .0001).
CONCLUSIONS: Increased LV rotation and twist are present in children with genotype-positive, phenotype-negative HCM. Apical rotation on speckle-tracking echocardiography provides good sensitivity and specificity for the prediction of gene-positive HCM and may be a clinically useful early marker of HCM before the onset of hypertrophy.
Copyright © 2014 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  2D; Early detection; G+P−; Genotype-positive, phenotype-negative; HCM; Hypertrophic cardiomyopathy; LV; Left ventricular; ROC; Receiver operating characteristic; STE; Speckle-tracking echocardiography; Strain; Two-dimensional

Mesh:

Year:  2013        PMID: 24325958     DOI: 10.1016/j.echo.2013.10.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  18 in total

Review 1.  Reference Ranges of Left Ventricular Strain Measures by Two-Dimensional Speckle-Tracking Echocardiography in Children: A Systematic Review and Meta-Analysis.

Authors:  Philip T Levy; Aliza Machefsky; Aura A Sanchez; Meghna D Patel; Sarah Rogal; Susan Fowler; Lauren Yaeger; Angela Hardi; Mark R Holland; Aaron Hamvas; Gautam K Singh
Journal:  J Am Soc Echocardiogr       Date:  2015-12-30       Impact factor: 5.251

2.  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.

Authors:  Eric M Green; Hiroko Wakimoto; Robert L Anderson; Marc J Evanchik; Joshua M Gorham; Brooke C Harrison; Marcus Henze; Raja Kawas; Johan D Oslob; Hector M Rodriguez; Yonghong Song; William Wan; Leslie A Leinwand; James A Spudich; Robert S McDowell; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2016-02-05       Impact factor: 47.728

3.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

4.  Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin.

Authors:  Christopher N Toepfer; Hiroko Wakimoto; Amanda C Garfinkel; Barbara McDonough; Dan Liao; Jianming Jiang; Angela C Tai; Joshua M Gorham; Ida G Lunde; Mingyue Lun; Thomas L Lynch; James W McNamara; Sakthivel Sadayappan; Charles S Redwood; Hugh C Watkins; Jonathan G Seidman; Christine E Seidman
Journal:  Sci Transl Med       Date:  2019-01-23       Impact factor: 17.956

5.  Abnormal Mitral Valve Dimensions in Pediatric Patients with Hypertrophic Cardiomyopathy.

Authors:  Daryl Schantz; Lee Benson; Jonathan Windram; Derek Wong; Andreea Dragulescu; Shi-Joon Yoo; Luc Mertens; Mark Friedberg; Bahiyah Al Nafisi; Lars Grosse-Wortmann
Journal:  Pediatr Cardiol       Date:  2016-03-09       Impact factor: 1.655

Review 6.  Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside.

Authors:  Chiara Palandri; Lorenzo Santini; Alessia Argirò; Francesca Margara; Ruben Doste; Alfonso Bueno-Orovio; Iacopo Olivotto; Raffaele Coppini
Journal:  Drugs       Date:  2022-06-13       Impact factor: 11.431

7.  Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Authors:  Morten K Jensen; Ole Havndrup; Michael Christiansen; Paal S Andersen; Anna Axelsson; Lars Køber; Henning Bundgaard
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-01       Impact factor: 2.357

8.  Normal left ventricular torsion mechanics in healthy children: age related changes of torsion parameters are closely related to changes in heart rate.

Authors:  Hye Jin Kim; Ji-Hong Yoon; Eun-Jung Lee; Jin Hee Oh; Jae Young Lee; Soon Ju Lee; Ji Whan Han
Journal:  Korean Circ J       Date:  2015-03-24       Impact factor: 3.243

9.  Association between genetic variants in the HIF1A-VEGF pathway and left ventricular regional myocardial deformation in patients with hypertrophic cardiomyopathy.

Authors:  Guido E Pieles; Jaime Alkon; Cedric Manlhiot; Chun-Po Steve Fan; Caroline Kinnear; Leland N Benson; Seema Mital; Mark K Friedberg
Journal:  Pediatr Res       Date:  2020-05-06       Impact factor: 3.756

Review 10.  Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options.

Authors:  Cristian Stătescu; Ștefana Enachi; Carina Ureche; Laura Țăpoi; Larisa Anghel; Delia Șalaru; Carmen Pleșoianu; Mădălina Bostan; Dragoș Marcu; Mircea Ovanez Balasanian; Radu Andy Sascău
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.